A Phase II trial of Denileukin Diftitox in patients with previously treated advanced non-small cell lung cancer. [electronic resource]
Producer: 20091201Description: 269-73 p. digitalISSN:- 1537-453X
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Agents -- therapeutic use
- Carcinoma, Non-Small-Cell Lung -- drug therapy
- Diphtheria Toxin -- therapeutic use
- Drug Resistance, Neoplasm
- Female
- Humans
- Interleukin-2 -- therapeutic use
- Lung Neoplasms -- drug therapy
- Male
- Maximum Tolerated Dose
- Middle Aged
- Neoplasm Recurrence, Local -- drug therapy
- Neoplasm Staging
- Prognosis
- Recombinant Fusion Proteins -- therapeutic use
- Survival Rate
- Treatment Outcome
- Young Adult
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.